// App-Quantinova.ai

1316 : Targeted therapeutic approach for triple negative breast cancer using paramagnetic nanoparticle

Researchers

Presenter

  • Meser M. Ali

Principal Investigators

  • Li Zhang

  • Hassan Bagher Ebadian

  • James R. Ewing

Medical Centers

  • Henry Ford Hosp, Detroit, MI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved